For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Heartlander
GMO Labeling to Appear on Washington Ballot
Gregory Conko, a senior fellow at the Competitive Enterprise Institute, says consumers have a right to know if products they purchase have negative health consequences.
Blog
Economic Freedom Declines Again; Government Control Is Bad For Your Health
Economic freedom has declined under the Obama administration, and America's rank has repeatedly fallen on the Index of Economic Freedom and other rankings issued…
Blog
Obamacare Increases Unnecessary Medical Tests, Wastes Doctors’ Time, Drives Up Billings And Costs
President Obama claimed Obamacare would cut healthcare costs, but it actually increased them in many ways, some of which are chronicled here. Here are yet…
Blog
Obamacare Imposes New Fees, Cost Increases On The Public
Obamacare was sold to the public based on the fallacy that it would cut healthcare costs, but each month brings additional evidence that it…
Cato
The Ripple Effects of Flawed Agbiotech Regulation
The modern techniques of genetic engineering—also known as biotechnology, recombinant DNA technology, or genetic modification (GM)—offer plant breeders the tools to make old crop plants…
Blog
Appeals Court Overturns Dismissal Of Challenge To Obamacare Contraception Mandate By Religious Colleges
According to law professor Jonathan Adler, the U.S. Court of Appeals for the D.C. Circuit effectively overturned a district court’s dismissal of a challenge…